Article Text

PDF

High dose pancreatic enzymes in cystic fibrosis.
  1. P J Robinson,
  2. P D Sly
  1. Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.

    Abstract

    Seven patients with cystic fibrosis taking high doses of pancreatin supplements were assessed to determine whether this dose was necessary to achieve adequate fat absorption. Patients reduced their intake from a group mean of 45 to 21 capsules a day. Five patients did not have any significant alteration in fat malabsorption while taking the reduced enzyme dose.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.